Skip to main content
Top

Drugs

Issue 5/2025

Content (11 Articles)

The Tailored Biosimilar Approach: Expectations and Requirements

  • Open Access
  • Current Opinion

Elena Guillen, Sean Barry, Nils Jost, Niklas Ekman, Verena Knippel, Johanna Kuhlmann-Gottke, Julia Maier, Martina Weise, Andrea Laslop, René Anour, Ger van Zandbergen, Nadine Kirsch‑Stefan

Current Drug Treatment for Acute and Recurrent Pericarditis

Aldo Bonaventura, Davide Santagata, Alessandra Vecchié, Antonio Abbate

The Potential of RNA Therapeutics in Treating Cardiovascular Disease

  • Review Article

Gayatri Mainkar, Matteo Ghiringhelli, Lior Zangi

Zanidatamab: First Approval

Susan J. Keam

Stapokibart: First Approval

Matt Shirley

Correction: From Prospective Evaluation to Practice: Model-Informed Dose Optimization in Oncology

  • Open Access
  • Correction

Bram C. Agema, Birgit C. P. Koch, Ron H. J. Mathijssen, Stijn L. W. Koolen